Clinical Trial Update: Mindfulness-based Psilocybin Therapy for PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating mindfulness-based psilocybin therapy for post-traumatic stress disorder and major depressive disorder; status is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Anthony P King | Conditions: Post Traumatic Stress Disorder, Depression - Major Depressive Disorder | Phase 2 | Status: NOT_YET_RECRUITING